Your browser doesn't support javascript.
loading
Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week therapy in patients with SLE.
Borg, Alexander; Gomez, Alvaro; Cederlund, Arvid; Cobar, Flordelyn; Qiu, Victor; Lindblom, Julius; Emamikia, Sharzad; Enman, Yvonne; Pettersson, Susanne; Parodis, Ioannis.
Afiliação
  • Borg A; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet.
  • Gomez A; Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital.
  • Cederlund A; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet.
  • Cobar F; Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital.
  • Qiu V; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet.
  • Lindblom J; Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital.
  • Emamikia S; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet.
  • Enman Y; Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital.
  • Pettersson S; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet.
  • Parodis I; Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital.
Rheumatology (Oxford) ; 60(9): 4205-4217, 2021 09 01.
Article em En | MEDLINE | ID: mdl-33404659
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sobrepeso / Anticorpos Monoclonais Humanizados / Imunossupressores / Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sobrepeso / Anticorpos Monoclonais Humanizados / Imunossupressores / Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2021 Tipo de documento: Article